Status:
UNKNOWN
Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
INSERM, Epopé team
Conditions:
covid19 Infection
Pregnancy Complications
Eligibility:
FEMALE
Brief Summary
The purpose of this study is to characterize the incidence and clinical features of the maternal COVID 19 infection, as well as the associated morbidity of the mother and the child, in the French cont...
Detailed Description
In the overall context of uncertainty about the morbidity associated with COVID-19 infection and its optimal management, knowledge is urgently required on infection during pregnancy. First, pregnant ...
Eligibility Criteria
Inclusion
- Any woman with :
- either proven COVID-19 infection= positive PCR test, OR probable COVID-19 infection = typical clinical symptoms AND typical pulmonary radiology
- during pregnancy or within 42 days postpartum,
- whether or not this diagnosis is followed by hospitalization,
Exclusion
- Refusal to participate
- Major protected (curator, trusteeship)
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
3060 Patients enrolled
Trial Details
Trial ID
NCT04463758
Start Date
May 11 2020
End Date
October 1 2022
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP Cochin
Paris, France, 75014